ADMA Biologics, Inc. (ADMA)

16.10 -0.22 (-1.38%) USD  |  NASDAQ  |  Feb 20, 15:59
More

ADMA Biologics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Arcutis Biotherapeutics, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Editas Medicine, Inc. Upgrade